Prellis Biologics
Michael E. Marks is the Founding Managing Partner at Celesta Capital since 2014. In addition to this role, Marks serves on the boards of multiple organizations, including Biomason, Autonomy, Alveo Technologies, Prellis Biologics, Slate Technologies Inc., Finicast, Inc., and MINA Group, with various tenures starting from 2020 to 2022. Marks holds the position of Chairman of the Board at both Carbitex and Onx Homes. Academic qualifications include a Master of Business Administration from Harvard Business School and dual degrees in Psychology (BA, MA) from Oberlin College.
This person is not in any teams
Prellis Biologics
Prellis Bio is hiring Immunologists! We are expanding our Externalized Immune System, EXIS™, platform with applications in antibody discovery, immunogenicity, and vaccine screening all in the same platform. Prellis Biologics, Inc. is a privately held company based in the San Francisco Bay Area, CA.